2019
DOI: 10.1111/jns.12341
|View full text |Cite
|
Sign up to set email alerts
|

Phrenic nerve involvement and respiratory muscle weakness in patients with Charcot‐Marie‐Tooth disease 1A

Abstract: Diaphragm weakness in Charcot‐Marie‐Tooth disease 1A (CMT1A) is usually associated with severe disease manifestation. This study comprehensively investigated phrenic nerve conductivity, inspiratory and expiratory muscle function in ambulatory CMT1A patients. Nineteen adults with CMT1A (13 females, 47 ± 12 years) underwent spiromanometry, diaphragm ultrasound, and magnetic stimulation of the phrenic nerves and the lower thoracic nerve roots, with recording of diaphragm compound muscle action potentials (dCMAP, … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
34
0
3

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

1
8

Authors

Journals

citations
Cited by 26 publications
(38 citation statements)
references
References 54 publications
1
34
0
3
Order By: Relevance
“…Discrimination of the pleural and peritoneal layers in these patient groups may also be more challenging than in healthy volunteers as some patients suffer from malnutrition and hypoalbunemia, possibly leading to anasarca. However, several studies have proven that diaphragm thickness can exactly be determined not only in healthy subjects but also in neuromuscular disease patients in whom these problems are not present [31][32][33][34][35][36]. Finally, we did not specifically measure SNIP in our study cohort.…”
Section: Discussionmentioning
confidence: 99%
“…Discrimination of the pleural and peritoneal layers in these patient groups may also be more challenging than in healthy volunteers as some patients suffer from malnutrition and hypoalbunemia, possibly leading to anasarca. However, several studies have proven that diaphragm thickness can exactly be determined not only in healthy subjects but also in neuromuscular disease patients in whom these problems are not present [31][32][33][34][35][36]. Finally, we did not specifically measure SNIP in our study cohort.…”
Section: Discussionmentioning
confidence: 99%
“…and the involvement of other organ systems may also occur [31,32]. Furthermore, the neurological deficits from HMSN also result in the secondary involvement of other systems, most commonly the skeletal system (for example, scoliosis [33] and orthopaedic injuries to the feet and ankles [34]) and respiratory system (due to phrenic nerve involvement [35], vocal cord paresis [36], or above-mentioned scoliosis).…”
Section: Genetic Peripheral Neuropathymentioning
confidence: 99%
“…In the sample, pGCI median score was 5, with a distribution ranging between 1 and 7, as shown in Figure 3. Noteworthy, nearly 80% of the sample patients either improved 4,5 or displayed a considerable improvement. 6,7 Six out of seven patients with pGIC <3 had a WHS score ≥4.…”
Section: Samplementioning
confidence: 96%
“…4 The disease is degenerative and usually shows a slow progression, involving the hands and the respiratory functions, consequently decreasing the patient's quality of life significantly. 5,6 Pharmacological treatments are under investigations; however, as of today, only the rehabilitative management of the disease seems to be of any real use. This includes physiotherapy to maintain joint mobility, to increase muscle strength, and to improve both postural control and endurance; the use of orthoses to enhance walking efficiency, and foot functional surgery (FS) to correct ankle deformities and to improve gait functionality.…”
Section: Introductionmentioning
confidence: 99%